Literature DB >> 8796847

Neuropathogenesis of AIDS.

S Dewhurst1, H A Gelbard, S M Fine.   

Abstract

Neurological disease directly attributable to HIV-1 infection (HIV dementia) is one of the most frequent disorders in persons with AIDS. HIV-1 dementia is associated with neuronal loss, but occurs in the absence of direct viral infection of neurons, suggesting that neurological damage occurs by an indirect mechanism. Recent studies have identified a number of candidate HIV-1 neurotoxins that may cause neuronal damage through common pathways involving the induction of oxidative stress and excitotoxicity. These findings suggest new therapeutic approaches to the prevention and treatment of HIV-1-induced neurological disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8796847     DOI: 10.1016/1357-4310(96)88754-5

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  8 in total

Review 1.  Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Authors:  Allison H Bartlett; Pyong Woo Park
Journal:  Expert Rev Mol Med       Date:  2010-02-01       Impact factor: 5.600

2.  Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients.

Authors:  David F Tate; Jared Conley; Robert H Paul; Kathryn Coop; Song Zhang; Wenjin Zhou; David H Laidlaw; Lynn E Taylor; Timothy Flanigan; Bradford Navia; Ronald Cohen; Karen Tashima
Journal:  Brain Imaging Behav       Date:  2010-01-19       Impact factor: 3.978

3.  Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains.

Authors:  Janelle M Silvers; Michael Y Aksenov; Marina V Aksenova; Jacob Beckley; Petra Olton; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

4.  Screening assay for oxidative stress in a feline astrocyte cell line, G355-5.

Authors:  Maria Pia Testa; Omar Alvarado; Andrea Wournell; Jonathan Lee; Frederick T Guilford; Steven H Henriksen; Tom R Phillips
Journal:  J Vis Exp       Date:  2011-07-13       Impact factor: 1.355

5.  Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.

Authors:  Antonella Bugatti; Chiara Urbinati; Cosetta Ravelli; Erik De Clercq; Sandra Liekens; Marco Rusnati
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

6.  Isolation and characterization of a neuropathogenic simian immunodeficiency virus derived from a sooty mangabey.

Authors:  F J Novembre; J De Rosayro; S P O'Neil; D C Anderson; S A Klumpp; H M McClure
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 7.  Molecular mechanisms of HIV-1 associated neurodegeneration.

Authors:  Hakan Ozdener
Journal:  J Biosci       Date:  2005-06       Impact factor: 2.795

8.  A triad of lys12, lys41, arg78 spatial domain, a novel identified heparin binding site on tat protein, facilitates tat-driven cell adhesion.

Authors:  Jing Ai; Xianliang Xin; Mingyue Zheng; Shuai Wang; Shuying Peng; Jing Li; Limei Wang; Hualiang Jiang; Meiyu Geng
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.